To ablate or operate? That is the question!

Journal of the American College of Cardiology

Volumn 38, Issue 6, 2001, Pages 1707-1710

  Wigle, E Douglas ^a   Schwartz, Leonard ^a   Woo, Anna ^a   Rakowski, Harry ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

AORTA VALVE REGURGITATION; ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; CONTRAST ENHANCEMENT; DEFIBRILLATOR; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART INFARCTION; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE CONDUCTION; HEART VENTRICLE SEPTUM; HEART VENTRICLE TACHYCARDIA; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERMETHOD COMPARISON; MITRAL VALVE REGURGITATION; MUSCLE RESECTION; NOTE; POSTOPERATIVE COMPLICATION; PRESSURE GRADIENT; PRIORITY JOURNAL;

EID: 0035890247     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01594-7     Document Type: Editorial

References (30)

1. The surgical management of obstructive cardiomyopathy
2. Surgical treatment of idiopathic hypertrophic subaortic stenosis. Technic and hemodynamic results of subaortic ventriculomyotomy
3. Surgical relief of diffuse subvalvular aortic stenosis
4. Results of ventriculomyotomy in muscular subaortic stenosis
5. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy
6. Hypertrophic obstructive cardiomyopathy: 10-21-Year follow-up after partial septal myectomy
7. Results of surgery for hypertrophic obstructive cardiomyopathy
8. Long-term clinical follow-up of surgical myectomy for hypertrophic obstructive cardiomyopathy
9. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
10. Medical and surgical treatment of the cardiomyopathies
11. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
12. Dual-chamber pacing for patients with hypertrophic cardiomyopathy: A prospective randomized double-blind crossover trial
13. Pacing in hypertrophic obstructive cardiomyopathy
14. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy (M-PATHY trial)
15. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points
16. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
17. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy
18. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy
19. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: One-year follow-up
20. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Results with respect to intraprocedural myocardial contrast echocardiography
21. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: Initial results and clarification of mechanism of benefit
22. Evaluation of left ventricular outflow tract area after sepal reduction in hypertrophic obstructive cardiomyopathy: A real-time three-dimensional echocardiographic study
23. Hypertrophic cardiomyopathy: The importance of the site and the event of hypertrophy: A review
24. Hypertrophic cardiomyopathy. Clinical spectrum and treatment
25. Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision making
26. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: Relationship to obstruction and relief with myectomy
27. Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy
28. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy
29. Aortic regurgitation: A common complication after surgery for hypertrophic obstructive cardiomyopathy
30. Age related acute results of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy